Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- FTC accuses Cephalon over Provigil in patent case
- The Federal Trade Commission filed a lawsuit yesterday against Cephalon Inc. over deals it struck with four makers of generic drugs that had challenged the patent on Cephalon's biggest drug, Provigil. The agreements, which the FTC said were worth more than $200 million, would prevent four companies - Teva Pharmaceutical...
- Research articles 2008-02-14
- Behind Cephalon's Numbers: a Big Cancer Bet and Signs of Skepticism
- The FDA delivered to Cephalon a letter yesterday saying it would not approve expanded indications for its pain drug Fentora until the company gave it more information on how it would prevent the drug from being abused. Even though the Fentora situation is fixable, it's just the sort of headache...
- Blog posts 2008-09-16
- Cephalon: Damn the Torpedoes! We're Raising Prices!
- A corporate strategy question for you about Cephalon: Your industry is unpopular because of its rising prices. Your company's marketing is under the control of the U.S. Department of Justice due to illegal off-label sales. One of your best-known brands is already facing generic competition, and one of your best-selling...
- Blog posts 2008-11-18
- Pharma Roundup: Cephalon Hikes Provigil Prices, Icahn Eyes Amylin, and More
- Cephalon hopes Provigil price hikes now will keep its customers later. Icahn wants Amylin, perhaps. Johnson & Johnson pays for Duragesic death. Anti-depressants may be equivalent. by John Maas
- Blog posts 2008-11-18
- Is Cephalon's Provigil Addictive? Ask the Cocaine-Using Monkeys It Was Tested On.
- Cephalon is dealing with a PR storm over the question of whether Provigil, its sleep disorder drug, is addictive or not. A study by the National Institute on Drug Abuse suggests that it is: Nora D. Volkow, MD, director of the National Institute on Drug Abuse NIDA, report[s] evidence...
- Blog posts 2009-03-18
- Cephalon Q2: Not Taking Nuvigil to Stay Awake Yet? You Will Be, Company Believes
- Cephalon is in the middle of a titanic struggle to move as many patients off its Provigil wakefulness drug onto its new brand, Nuvigil, which it just launched. Provigil goes off-patent sometime between now and April 2012, sooner if the FTC prevails in its anti pay-for-delay suit against the company....
- Blog posts 2009-08-06
- Generics Threaten Drugmaker Cephalon's Success
- Biotechnology watchers are measuring success at Cephalon on how quickly the drugmaker can convert patients on its soon-to-go generic blockbuster Provigil to regular users of its narcoleptic successor Nuvigil. As Jim Edwards at BNET Pharma astutely pointed out exactly one year ago, however, competition also threatens to derail...
- Blog posts 2009-09-21
Additional Resources
- Teva Announces Agreement with Cephalon Regarding Settlement of PROVIGIL® Patent Litigation; Parties Also Agree to Business Arrangements Related to Modafinil
- JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and Teva Pharmaceuticals USA, Inc. announced today that they have entered into an agreement with Cephalon, Inc. (Nasdaq: CEPH) to settle their pending patent infringement disputes in the United States and the United Kingdom related to PROVIGILR modafinil Tablets (C-IV).
- Research articles 2005-12-09
- Cephalon Chugs Along, Despite Fentora, Provigil Setbacks
- Zacks.com submits: By Jason Napodano, CFA Cephalon CEPH shares are currently trading at 9.6x our 2009 EPS estimate of $5.90 (fully-diluted). The shares declined significantly early last year on concerns regarding the growth prospects of Provigil and Fentora. by Zacks.com
- External links 2009-06-16
- Cephalon Inc. Q1 2009 Earnings Call Transcript
- Question-and-Answer SessionOperator We will take our first question from Jim Birchenough with Barclays. Jim Birchenough - Barclays Just wondering on the PROVIGIL number for the quarter, it was down 10%. I'm having trouble reconciling that with the price increase and what seemed to be relatively flat volume trends. Could...
- Earnings calls 2009-05-05
- Cephalon Q2 2007 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions We will take our first question from David Buck with Buckingham Research. David Buck - Buckingham Research Hi, yes. Thanks for taking my question. Just three quick questions. First for Frank or Kevin, what precipitated the reserve and the timing of the...
- Earnings calls 2007-07-31
- Cephalon Q1 2007 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions We'll go first to Eric Schmidt with Cowen & Company. Eric Schmidt - Cowen & Co. Good afternoon. Congratulations on a great quarter. Just looking for some more details around PROVIGIL. I notice you didn't break out the sales in Q1. Could...
- Earnings calls 2007-05-01
- "Pain Is Pain": Cephalon's Marketing Comes Under DOJ Control
- Cephalon agreed yesterday to a $444 million settlement with the Department of Justice that will control its marketing of Actiq, Provigil and Gabitril. (Scroll to the bottom of this page if you want to read the prosecutors' documents describing the scale of wrongdoing at the company.) The...
- Blog posts 2008-09-30
- Our Favorite Drug Company Conference Call Tap Dancers
- Drug company conference calls with Wall Street are often dull or baffling -- a fast tide of numbers and facts extracted by spreadsheet jocks. But they're often the only chance we have to hear CEOs and other senior execs talking without the benefit of prepared remarks. Every once in while...
- Blog posts 2008-11-13
- MODAFINIL.
- Cephalon Inc. reports that a clinical study of Provigil modafinil for treating adults with attention deficit hyperactivity disorder showed ... Cephalon Inc. reports that a clinical study of Provigil modafinil for treating adults with attention deficit hyperactivity disorder showed no benefit compared to...
- Research articles 2000-08-07
- Cephalon to Buy Lafon for $450 MM. (Breaking News Roundup).(France's Group Lafon)(Brief Article)
- Cephalon Inc. has agreed to acquire France's Group Lafon for $450 million, gaining control of worldwide rights to its flagship product Provigil modafinil tablets. SG Cowen estimates peak sales of the narcolepsy drug at over $500 million. Cephalon Cephalon Inc. has agreed to acquire...
- Research articles 2001-12-10
- International news
- Provigil approved in Mexico West Chester, PA-based Cephalon Inc.'s ProvigilR modafinil has been approved for sale in Mexico.The drug, indicated for the treatment of excessive daytime sleepiness associated with narcolepsy, will be marketed in Mexico under the brand name Modiodal by Armstrong Laboratorios de Mexico S.A.CV., based in Colonia Ejidos...
- Research articles 2002-03-01
- List of 56 Drugs That Should Not Be Mixed With Viagra Contains Some Surprises
- Public Citizen has published a list of 56 drugs that interact badly with erectile dysfunction pills such as Pfizer's Viagra. Public Citizen's WorstPills.com site reports: In combination with ED drugs, these 56 drugs can cause dangerous falls in blood pressure that could lead to a heart attack or stroke;...
- Blog posts 2009-01-06
- Cephalon, Inc., Q4 2008 Earnings Call Transcript
- Question-and-Answer SessionOperator Thank you. Operator Instructions. And we will first go to Chris Schott from J.P. Morgan. Chris Schott - J.P. Morgan Great. Thanks. Just a couple of questions. Maybe if Frank, start by talking a little bit about the kind of M&A environment you are...
- Earnings calls 2009-02-12
- Brain Steroids: Ban Or Boost?
- Drugs are bad for productivity, right? Well, maybe not. While you can probably correlate productivity increases with declines in per capita drinking, what about coffee or Diet Coke? These can act as mild stimulants. Then there's full-fledged brain steroids, say, a drug like Provigil, which...
- Blog posts 2008-03-24
- << Previous
- page 1 of 1
- Next >>
Content Types
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
